{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:17:01Z","timestamp":1792171021674,"version":"4.4.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.prp.2024.155136","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T18:55:40Z","timestamp":1705344940000},"page":"155136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Cervical cancer: Novel treatment strategies offer renewed optimism"],"prefix":"10.1016","volume":"254","author":[{"given":"Gangotri","family":"yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganga","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.prp.2024.155136_bib1","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.3390\/ijerph19127094","article-title":"New advances in cervical cancer: from bench to bedside","volume":"19","author":"D\u2019Oria","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s11042-021-10627-3","article-title":"Imaging based cervical cancer diagnostics using small object detection-generative adversarial networks","volume":"17","author":"Elakkiya","year":"2022","journal-title":"Multimed. Tools Appl."},{"key":"10.1016\/j.prp.2024.155136_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eswa.2019.112951","article-title":"A fully-automated deep learning pipeline for cervical cancer classification","volume":"141","author":"Alyafeai","year":"2020","journal-title":"Expert Syst. Appl."},{"key":"10.1016\/j.prp.2024.155136_bib4","doi-asserted-by":"crossref","unstructured":"Sebastien T.N. Prevalence of Cervical Cancer and Associating Factors among HIV Infected Women of Omaruru District in Namibia. Prevalence.10(1).","DOI":"10.21522\/TIJAR.2014.10.01.Art006"},{"issue":"4","key":"10.1016\/j.prp.2024.155136_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cyt.12835","article-title":"The early detection of cervical cancer. The current and changing landscape of cervical disease detection","volume":"31","author":"Shiraz","year":"2020","journal-title":"Cytopathology"},{"key":"10.1016\/j.prp.2024.155136_bib6","doi-asserted-by":"crossref","unstructured":"McCluggage W.G., Singh N., Gilks C.B. Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology. 2022;80(5):762\u201378.","DOI":"10.1111\/his.14609"},{"key":"10.1016\/j.prp.2024.155136_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.884548","article-title":"Repositioning of anti-inflammatory drugs for the treatment of cervical cancer Sub-types","volume":"13","author":"Kori","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.prp.2024.155136_bib8","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.3390\/cells11162528","article-title":"The interaction of human papillomavirus infection and prostaglandin E2 signaling in carcinogenesis: a focus on cervical cancer therapeutics","volume":"11","author":"Garc\u00eda-Quiroz","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.prp.2024.155136_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2019.11.039","article-title":"Human papillomavirus vaccine against cervical cancer: Opportunity and challenge","volume":"471","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2024.155136_bib10","first-page":"6","article-title":"Visual inspection of the cervix (VIA) versus colposcopy for evaluation of suspicious cervix","volume":"16","author":"Gadallah","year":"2019","journal-title":"Life Sci. J."},{"key":"10.1016\/j.prp.2024.155136_bib11","first-page":"20","article-title":"Automated detection and classification of cervical cancer using pap smear microscopic images: A comprehensive review and future perspectives","volume":"19","author":"Shanthi","year":"2022","journal-title":"Eng. Sci."},{"issue":"4","key":"10.1016\/j.prp.2024.155136_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pop.2021.07.008","article-title":"Management of cervical dysplasia using office loop electrosurgical excision procedure","volume":"48","author":"Ram\u00edrez","year":"2021","journal-title":"Prim. Care: Clin. Off. Pract."},{"key":"10.1016\/j.prp.2024.155136_bib13","first-page":"34","article-title":"Volume, shape and dimensions analysis of the tissue specimen after the cervical conization","volume":"2022","author":"Kislingerov\u00e1","year":"2022","journal-title":"Instrum. Methods Biol. Med."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib14","first-page":"53","article-title":"The diagnostics and treatment of cervical cancer","volume":"75","author":"Hrgovi\u0107","year":"2021","journal-title":"Acta Med. Croat.: \u010casopis Akad. Med. Znan. Hrvat."},{"issue":"24","key":"10.1016\/j.prp.2024.155136_bib15","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.3390\/ijms222413543","article-title":"Infection by high-risk human papillomaviruses, epithelial-to-mesenchymal transition and squamous pre-malignant or malignant lesions of the uterine cervix: a series of chained events?","volume":"22","author":"Barillari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.prp.2024.155136_bib16","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.3390\/ijms23094723","article-title":"Interplay between cell death and cell proliferation reveals new strategies for cancer therapy","volume":"23","author":"Loftus","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.prp.2024.155136_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/medicina55070384","article-title":"Key molecular events in cervical cancer development","volume":"55","author":"Balasubramaniam","year":"2019","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib18","first-page":"1","article-title":"Cervical cancer in Ethiopia: a review of the literature","volume":"34","author":"Derbie","year":"2023","journal-title":"Cancer Causes Control."},{"issue":"4","key":"10.1016\/j.prp.2024.155136_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2022.13233","article-title":"Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries","volume":"23","author":"Bogdanova","year":"2022","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-019-0736-z","article-title":"Barriers to cervical screening among older women from hard-to-reach groups: a qualitative study in England","volume":"19","author":"Marlow","year":"2019","journal-title":"BMC Women'S. Health"},{"key":"10.1016\/j.prp.2024.155136_bib21","unstructured":"Tzafetas M. The importance of clearance during surgical excision in pre-invasive and invasive cervical disease with the use of new innovative technologies to aid fertility preservation. 2021."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib22","first-page":"6","article-title":"Loop electrosurgical excision procedure in a low-resource setting: feasibility of selective see-and-treat approach","volume":"19","author":"Vijayashanti","year":"2021","journal-title":"Indian J. Gynecol. Oncol."},{"key":"10.1016\/j.prp.2024.155136_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00404-020-05661-9","article-title":"Psychological distress in cervical cancer screening: results from a German online survey","volume":"302","author":"Jentschke","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.prp.2024.155136_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2147\/IJGM.S280576","article-title":"Risk factors for residual disease in hysterectomy specimens after conization in post-menopausal patients with cervical intraepithelial neoplasia grade 3","author":"Sun","year":"2020","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.prp.2024.155136_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/CEJ.0000000000000770","article-title":"Cervical cancer screening and outcomes for women under 25 years of age in Belgium: a 10-year nationwide study","volume":"32","author":"Desimpel","year":"2023","journal-title":"Eur. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.prp.2024.155136_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1517\/17425240903158917","article-title":"Biodegradable amphiphilic polymer\u2013drug conjugate micelles","volume":"6","author":"Hu","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"issue":"35","key":"10.1016\/j.prp.2024.155136_bib27","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1021\/acs.jafc.8b02698","article-title":"Biotin-modified polylactic-co-glycolic acid nanoparticles with improved antiproliferative activity of 15, 16-dihydrotanshinone I in human cervical cancer cells","volume":"66","author":"Luo","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"35","key":"10.1016\/j.prp.2024.155136_bib28","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1021\/acs.jafc.8b02698","article-title":"Biotin-modified polylactic- co-glycolic acid nanoparticles with improved antiproliferative activity of 15,16-dihydrotanshinone i in human cervical cancer cells","volume":"66","author":"Luo","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.prp.2024.155136_bib29","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.12659\/MSM.915329","article-title":"Long non-coding RNA (lncRNA) X-Inactive Specific Transcript (XIST) plays a critical role in predicting clinical prognosis and progression of colorectal cancer","volume":"25","author":"Zhang","year":"2019","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"issue":"6","key":"10.1016\/j.prp.2024.155136_bib30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2174\/1381612826666191227154009","article-title":"Pathophysiological functions of the lncRNA TUG1","volume":"26","author":"Guo","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.prp.2024.155136_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/CCO.0000000000000471","article-title":"The management of locally advanced cervical cancer","volume":"30","author":"Ch","year":"2018","journal-title":"Curr. Opin. Oncol."},{"issue":"15","key":"10.1016\/j.prp.2024.155136_bib32","first-page":"1768","article-title":"Current treatment for cervical cancer: an update","volume":"20","author":"Sharma","year":"2020","journal-title":"Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem. -Anti-Cancer Agents)"},{"issue":"4","key":"10.1016\/j.prp.2024.155136_bib33","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e82","article-title":"A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial","volume":"30","author":"Tangjitgamol","year":"2019","journal-title":"J. Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.prp.2024.155136_bib34","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-2656","article-title":"Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer","volume":"8","author":"Borcoman","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/14656566.2022.2084689","article-title":"Combinational therapies for the treatment of advanced cervical cancer","volume":"24","author":"Duenas-Gonzalez","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.prp.2024.155136_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01249","article-title":"The latest battles between EGFR monoclonal antibodies and resistant tumor cells","volume":"10","author":"Cai","year":"2020","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2024.155136_bib37","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/biomedicines11072000","article-title":"Nab-paclitaxel in the treatment of gastrointestinal cancers\u2014improvements in clinical efficacy and safety","volume":"11","author":"Hassan","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.prp.2024.155136_bib38","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/biom12060815","article-title":"Inhibitors of the cancer target ribonucleotide reductase, past and present","volume":"12","author":"Huff","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2024.155136_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154473","article-title":"Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies; a rapidly evolving strategy","author":"Nikoo","year":"2023","journal-title":"Pathol. -Res. Pract."},{"issue":"2","key":"10.1016\/j.prp.2024.155136_bib40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/ijmr.IJMR_1047_20","article-title":"Advances in management of locally advanced cervical cancer","volume":"154","author":"Musunuru","year":"2021","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.prp.2024.155136_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01067","article-title":"Randomized phase II trial of triapine-cisplatin-radiotherapy for locally advanced stage uterine cervix or vaginal cancers","volume":"9","author":"Kunos","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ygyno.2019.12.034","article-title":"Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528\/NRG-GY002)","volume":"157","author":"Santin","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"18","key":"10.1016\/j.prp.2024.155136_bib43","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.3390\/cancers14184458","article-title":"Immune landscape and immunotherapy options in cervical carcinoma","volume":"14","author":"Kousar","year":"2022","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.prp.2024.155136_bib44","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.3390\/cancers13215480","article-title":"Nano-based drug delivery and targeting to overcome drug resistance of ovarian cancers","volume":"13","author":"McFadden","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.prp.2024.155136_bib45","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.prp.2024.155136_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.msec.2018.09.044","article-title":"Synthesis of multifunctional Fe3O4@ PLGA-PEG nano-niosomes as a targeting carrier for treatment of cervical cancer","volume":"94","author":"You","year":"2019","journal-title":"Mater. Sci. Eng.: C."},{"key":"10.1016\/j.prp.2024.155136_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.104988","article-title":"Morin hydrate loaded solid lipid nanoparticles: characterization, stability, anticancer activity, and bioavailability","volume":"233","author":"Karamchedu","year":"2020","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.prp.2024.155136_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6121328","article-title":"Silver nanoparticles potentiates cytotoxicity and apoptotic potential of camptothecin in human cervical cancer cells","volume":"2018","author":"Yuan","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.prp.2024.155136_bib49","first-page":"1","article-title":"Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study","author":"Alghamdi","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.prp.2024.155136_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2019.03.015","article-title":"Threatening cancer with nanoparticle aided combination oncotherapy","volume":"301","author":"Rawal","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.prp.2024.155136_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111389","article-title":"Phytochemical delivery through nanocarriers: a review","volume":"197","author":"Ahmad","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.prp.2024.155136_bib52","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.2147\/IJN.S182475","article-title":"A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment","author":"Chen","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.prp.2024.155136_bib53","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1021\/acs.molpharmaceut.9b00717","article-title":"Transferrin-functionalized microemulsions coloaded with coix seed oil and tripterine deeply penetrate to improve cervical cancer therapy","volume":"16","author":"Guo","year":"2019","journal-title":"Mol. Pharm."},{"issue":"19","key":"10.1016\/j.prp.2024.155136_bib54","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1039\/D1BM00639H","article-title":"Recent progress in nanotechnology-based drug carriers for celastrol delivery","volume":"9","author":"Guo","year":"2021","journal-title":"Biomater. Sci."},{"issue":"45","key":"10.1016\/j.prp.2024.155136_bib55","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.prp.2024.155136_bib56","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/pharmaceutics14091886","article-title":"Review on the scale-up methods for the preparation of solid lipid nanoparticles","volume":"14","author":"Khairnar","year":"2022","journal-title":"Pharmaceutics"},{"issue":"45","key":"10.1016\/j.prp.2024.155136_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903156","article-title":"On the structure of solid lipid nanoparticles","volume":"15","author":"Pink","year":"2019","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.prp.2024.155136_bib58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/nano9030474","article-title":"Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs","volume":"9","author":"Bay\u00f3n-Cordero","year":"2019","journal-title":"Nanomaterials"},{"issue":"45","key":"10.1016\/j.prp.2024.155136_bib59","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1002\/chem.201701806","article-title":"Shape\u2010controlled hollow mesoporous silica nanoparticles with multifunctional capping for in vitro cancer treatment","volume":"23","author":"Geng","year":"2017","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.prp.2024.155136_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.580118","article-title":"Lipid nanoparticles as carriers for bioactive delivery","volume":"9","author":"Dhiman","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.prp.2024.155136_bib61","article-title":"The use of TPGS in drug delivery systems to overcome biological barriers","volume":"142","author":"Luiz","year":"2021","journal-title":"Eur. Polym. J."},{"issue":"13","key":"10.1016\/j.prp.2024.155136_bib62","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/polym14132601","article-title":"Approaches to improve macromolecule and nanoparticle accumulation in the tumor microenvironment by the enhanced permeability and retention effect","volume":"14","author":"Ejigah","year":"2022","journal-title":"Polymers"},{"issue":"11","key":"10.1016\/j.prp.2024.155136_bib63","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s13204-021-02018-9","article-title":"Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment","volume":"12","author":"Hussein","year":"2022","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.prp.2024.155136_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.605037","article-title":"Glycosylated nanoparticles for cancer-targeted drug delivery","volume":"10","author":"Torres-P\u00e9rez","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2024.155136_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100024","article-title":"Combination therapy based on nano codelivery for overcoming cancer drug resistance","volume":"6","author":"Wang","year":"2020","journal-title":"Med. Drug Discov."},{"issue":"12","key":"10.1016\/j.prp.2024.155136_bib66","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.3390\/molecules26123610","article-title":"Polymeric drug delivery system based on pluronics for cancer treatment","volume":"26","author":"Yu","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.prp.2024.155136_bib67","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.3390\/ijms24076199","article-title":"Solid lipid nanoparticles: applications and prospects in cancer treatment","volume":"24","author":"Sivadasan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.prp.2024.155136_bib68","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.prp.2024.155136_bib69","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4103\/0366-6999.235111","article-title":"Pelvic exenteration for recurrent and persistent cervical cancer","volume":"131","author":"Li","year":"2018","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.prp.2024.155136_bib70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejca.2021.02.009","article-title":"Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2)","volume":"148","author":"Mathevet","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib71","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brachy.2016.09.011","article-title":"Differences in outcome for cervical cancer patients treated with or without brachytherapy","volume":"16","author":"Karlsson","year":"2017","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.prp.2024.155136_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100557","article-title":"Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer","volume":"44","author":"Choi","year":"2020","journal-title":"Curr. Probl. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2014.01.042","article-title":"A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer","volume":"133","author":"Lorusso","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2024.155136_bib74","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ygyno.2022.04.011","article-title":"Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079)","volume":"165","author":"Tanigawa","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2024.155136_bib75","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ygyno.2015.09.079","article-title":"Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer","volume":"139","author":"Kim","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2024.155136_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4314\/mmj.v27i3.4","article-title":"A review of patients with advanced cervical cancer presenting to palliative care services at Queen Elizabeth Central Hospital in Blantyre, Malawi","volume":"27","author":"Bates","year":"2015","journal-title":"Malawi Med. J."},{"issue":"9930","key":"10.1016\/j.prp.2024.155136_bib77","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","article-title":"Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial","volume":"383","author":"Zimmermann","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2024.155136_bib78","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2147\/OTT.S186451","article-title":"Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis","volume":"12","author":"Zhao","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.prp.2024.155136_bib79","article-title":"PD-1\/PD-L1 immune checkpoint inhibitors in advanced cervical cancer","volume":"5","author":"Saglam","year":"2018","journal-title":"Integr. Cancer Sci. Ther."},{"key":"10.1016\/j.prp.2024.155136_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102385","article-title":"Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials","volume":"106","author":"Monk","year":"2022","journal-title":"Cancer Treat. Rev."},{"issue":"15","key":"10.1016\/j.prp.2024.155136_bib81","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S1470-2045(15)00220-X","article-title":"Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"16","author":"Symonds","year":"2015","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.prp.2024.155136_bib82","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ygyno.2020.11.031","article-title":"Racial and ethnic disparities in palliative care utilization among gynecological cancer patients","volume":"160","author":"Islam","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2024.155136_bib83","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcis.2022.04.031","article-title":"Potential of curcumin-loaded cubosomes for topical treatment of cervical cancer","volume":"620","author":"Victorelli","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.prp.2024.155136_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100177","article-title":"Recent advancements in the targeted delivery of Gemcitabine: harnessing Nanomedicine for Enhanced Cancer Therapy","author":"Pourmadadi","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.prp.2024.155136_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9184284","article-title":"Recent trends in nanocarrier-based targeted chemotherapy: selective delivery of anticancer drugs for effective lung, colon, cervical, and breast cancer treatment","volume":"2020","author":"Jin","year":"2020","journal-title":"J. Nanomater."},{"key":"10.1016\/j.prp.2024.155136_bib86","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations","volume":"54","author":"M\u00fcller","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.prp.2024.155136_bib87","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/17425247.2020.1737672","article-title":"The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis","volume":"17","author":"Zahednezhad","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.prp.2024.155136_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4504936","article-title":"Antitumor effects of curcumin and glycyrrhetinic acid-modified curcumin-loaded cationic liposome by intratumoral administration","volume":"2020","author":"Chang","year":"2020","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"4","key":"10.1016\/j.prp.2024.155136_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.9723","article-title":"Analysis of the cytotoxic effects, cellular uptake and cellular distribution of paclitaxel\u2011loaded nanoparticles in glioblastoma cells in vitro","volume":"21","author":"Wang","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.prp.2024.155136_bib90","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/cancers12102783","article-title":"Recent progress of nanocarrier-based therapy for solid malignancies","volume":"12","author":"Wei","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155136_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213344","article-title":"Synchronized delivery of dual-drugs for potentiating combination chemotherapy based on smart triple-responsive polymeric micelles","volume":"147","author":"Liu","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.prp.2024.155136_bib92","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s10904-021-01925-2","article-title":"Applications of dendrimers in nanomedicine and drug delivery: a review","volume":"31","author":"Nikzamir","year":"2021","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"10.1016\/j.prp.2024.155136_bib93","article-title":"Synthesis and immunogenicity of the linear conjugates of polyacrylic acid and antigenic peptide of human papillomavirus","volume":"176","author":"Eguz","year":"2022","journal-title":"Eur. Polym. J."},{"issue":"52","key":"10.1016\/j.prp.2024.155136_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202103072","article-title":"All\u2010in\u2010One Nanomedicine: Multifunctional Single\u2010Component Nanoparticles for Cancer Theranostics","volume":"17","author":"Cai","year":"2021","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.prp.2024.155136_bib95","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/molecules25071630","article-title":"Walnut oil prevents scopolamine-induced memory dysfunction in a mouse model","volume":"25","author":"Liao","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.prp.2024.155136_bib96","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/pharmaceutics13050707","article-title":"Anticancer potential of biogenic silver nanoparticles: a mechanistic study","volume":"13","author":"Khan","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.prp.2024.155136_bib97","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00210-022-02245-z","article-title":"Nanotechnology in drug and gene delivery","volume":"395","author":"Hamimed","year":"2022","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib98","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1080\/21691401.2019.1614017","article-title":"Photosynthesized gold nanoparticles from Catharanthus roseus induces caspase-mediated apoptosis in cervical cancer cells (HeLa)","volume":"47","author":"Ke","year":"2019","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-29821-4","article-title":"An insight into synthesis and antitumor activity of citrate and gallate stabilizing gold nanospheres","volume":"13","author":"Fathy","year":"2023","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.prp.2024.155136_bib100","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.3390\/molecules26195847","article-title":"An insight into FDA approved antibody-drug conjugates for cancer therapy","volume":"26","author":"Tong","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.prp.2024.155136_bib101","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1470-2045(18)30859-3","article-title":"Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1\u20132 trial","volume":"20","author":"de Bono","year":"2019","journal-title":"Lancet Oncol."},{"issue":"26","key":"10.1016\/j.prp.2024.155136_bib102","doi-asserted-by":"crossref","first-page":"22496","DOI":"10.18632\/oncotarget.4318","article-title":"Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)","volume":"6","author":"Goldenberg","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.prp.2024.155136_bib103","doi-asserted-by":"crossref","first-page":"234","DOI":"10.31033\/ijrasb.7.6.33","article-title":"Intra Vaginal drug delivery system (novel drug delivery system)","volume":"7","author":"Kumar","year":"2020","journal-title":"Int. J. Res. Appl. Sci. Biotechnol. (IJRASB)"},{"issue":"5","key":"10.1016\/j.prp.2024.155136_bib104","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.ijrobp.2020.11.052","article-title":"Localized delivery of cisplatin to cervical cancer improves its therapeutic efficacy and minimizes its side effect profile","volume":"109","author":"Federico","year":"2021","journal-title":"Int. J. Radiat. Oncol. * Biol. * Phys."},{"key":"10.1016\/j.prp.2024.155136_bib105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.addr.2021.04.009","article-title":"Vaginal drug delivery approaches for localized management of cervical cancer","volume":"174","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.prp.2024.155136_bib106","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/pharmaceutics12121185","article-title":"A bilayer vaginal tablet for the localized delivery of disulfiram and 5-fluorouracil to the cervix","volume":"12","author":"Abidin","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2024.155136_bib107","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijbiomac.2020.04.237","article-title":"Chemically crosslinked xylan\u2013\u03b2-Cyclodextrin hydrogel for the in vitro delivery of curcumin and 5-Fluorouracil","volume":"158","author":"Gami","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.prp.2024.155136_bib108","doi-asserted-by":"crossref","unstructured":"Chituku T., Jones S., Phillips R. The Development of Locoregional Therapies as a Strategy for Reducing Cervical Cancer Mortality in Low to Middle Income Countries. Authorea. 2022.","DOI":"10.22541\/au.164873341.16568307\/v1"},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib109","doi-asserted-by":"crossref","first-page":"1335567","DOI":"10.1080\/20022727.2017.1335567","article-title":"Possible role of nanocarriers in drug delivery against cervical cancer","volume":"8","author":"Gupta","year":"2017","journal-title":"Nano Rev. Exp."},{"key":"10.1016\/j.prp.2024.155136_bib110","article-title":"A review on allopathic and herbal nanofibrous drug delivery vehicles for cancer treatments","volume":"31","author":"Mateti","year":"2021","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.prp.2024.155136_bib111","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.prp.2024.155136_bib112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/OGX.0000000000000762","article-title":"Minimally invasive radical hysterectomy for cervical cancer: when adoption of a novel treatment precedes prospective, randomized evidence","volume":"75","author":"Melamed","year":"2020","journal-title":"Obstet. Gynecol. Surv."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib113","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2020.12.036","article-title":"Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: a national study in the United States","volume":"161","author":"Matsuo","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2024.155136_bib114","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino","year":"2020","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.prp.2024.155136_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00520","article-title":"Long-term survival and late toxicity associated with pelvic intensity modulated radiation therapy (IMRT) for cervical cancer involving CT-based positive lymph nodes","volume":"9","author":"Lei","year":"2019","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2024.155136_bib116","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2021-003056","article-title":"Image-guided brachytherapy in cervical cancer including fractionation","volume":"32","author":"Sturdza","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.prp.2024.155136_bib117","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: Current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med."},{"issue":"11","key":"10.1016\/j.prp.2024.155136_bib118","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/14737159.2020.1835472","article-title":"Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection","volume":"20","author":"Molina","year":"2020","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.prp.2024.155136_bib119","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/13543784.2023.2179483","article-title":"Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?","volume":"32","author":"Vergote","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.prp.2024.155136_bib120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-020-02028-0","article-title":"Organoids of the female reproductive tract","volume":"99","author":"Chumduri","year":"2021","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.prp.2024.155136_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1124591","article-title":"Interactions between microbiota and cervical epithelial, immune, and mucus barrier","volume":"13","author":"Dong","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.prp.2024.155136_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114543","article-title":"In vitro and ex vivo models for evaluating vaginal drug delivery systems","author":"Shapiro","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.prp.2024.155136_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103712","article-title":"Recent advances on drug delivery applications of mucopenetrative\/mucoadhesive particles: A review","author":"Puri","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"21","key":"10.1016\/j.prp.2024.155136_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/ani12213030","article-title":"Reproductive losses and their causes in alpacas-a survey-based study","volume":"12","author":"Kapustka","year":"2022","journal-title":"Animals"},{"key":"10.1016\/j.prp.2024.155136_bib125","unstructured":"Duffy A. HPV Vaccination and Cervical Cancer Prevention in Women: Walden University; 2021."},{"issue":"6","key":"10.1016\/j.prp.2024.155136_bib126","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/1389200221666210105121532","article-title":"An update on the recent advances in cubosome: a novel drug delivery system","volume":"22","author":"Garg","year":"2021","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.prp.2024.155136_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-020-00731-7","article-title":"Therapeutic role of curcumin and its novel formulations in gynecological cancers","volume":"13","author":"Pourhanifeh","year":"2020","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.prp.2024.155136_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.colcom.2021.100561","article-title":"Cubosomes in cancer drug delivery: a review","volume":"46","author":"Varghese","year":"2022","journal-title":"Colloid Interface Sci. Commun."},{"key":"10.1016\/j.prp.2024.155136_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12551-023-01089-y","article-title":"A short review on the applicability and use of cubosomes as nanocarriers","volume":"15","author":"Palma","year":"2023","journal-title":"Biophys. Rev."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:59:13Z","timestamp":1767167953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":129,"alternative-id":["S0344033824000475"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155136","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cervical cancer: Novel treatment strategies offer renewed optimism","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155136"}}